Results 71 to 80 of about 813,902 (172)

Candidoses invasives en reanimation. [Invasive candidiasis in critically ill patients]

open access: yes, 2000
Invasive candidiasis is rare in the general population (about 8 episodes/100,000/year), but has a higher incidence in hospitalised patients (0.5/1000 admissions). It complicates about 10 per 1000 admissions in critical care, where it represents 10-15% of
Eggimann, P., Pittet, D.
core   +1 more source

Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management Strategies

open access: yesJournal of Fungi, 2016
Mortality rates due to invasive candidiasis remain unacceptably high, in part because the poor sensitivity and slow turn-around time of cultures delay the initiation of antifungal treatment.
Cornelius J. Clancy   +2 more
doaj   +1 more source

The oral microbiota and periodontal health in orthodontic patients

open access: yesPeriodontology 2000, EarlyView.
Abstract The oral microbiota develops within the first 2 years of childhood and becomes distinct from the parents by 4 years‐of‐age. The oral microbiota plays an important role in the overall health/symbiosis of the individual. Deviations from the state of symbiosis leads to dysbiosis and an increased risk of pathogenicity.
Brandon W. Peterson   +4 more
wiley   +1 more source

Implant therapy in older patients: Prosthetic considerations and biomechanical implications for frailty/aging

open access: yesPeriodontology 2000, EarlyView.
Abstract Background Population aging is reshaping prosthodontic care for both partially and completely edentulous individuals. In older adults, conditions such as frailty, comorbidities, polypharmacy, and cognitive decline can have a direct impact on the biological and biomechanical demands of implant therapy, thereby influencing the success of implant
Yu‐Ting Yeh   +10 more
wiley   +1 more source

Changes in the treatment of invasive candidiasis due to C. glabrata over time.

open access: yes, 2014
Changes in the treatment of invasive candidiasis due to C. glabrata over time.
Billy Franks (592009)   +7 more
core   +1 more source

The assessment of therapeutic response of oropharyngeal and oesophageal candidiasis in AIDS using a new scoring system: studies with D0870. [PDF]

open access: yes, 1999
We developed and compared five scoring systems designed to quantitate therapeutic response in cases of oropharyngeal candidiasis. We utilized prospectively collected data on 114 patients treated with several doses of the azole D0870.
Williams, Keith   +7 more
core   +2 more sources

Invasive Fungal Infections in Heart Transplants: A 10‐Year, Single Centre Retrospective Cohort Study From Subtropical Australia

open access: yesTransplant Infectious Disease, EarlyView.
In this 10‐year retrospective cohort study of heart transplant recipients in subtropical Australia, we characterize the incidence and microbiological profile of invasive fungal infections, highlighting the underappreciated burden of late‐onset and non‐Aspergillus mold infections and the potential underdiagnosis of polymicrobial disease.
Angus Lane   +7 more
wiley   +1 more source

A multi‐omics investigation of sarcopenia and frailty: Integrating genomic, epigenomic and telomere length data

open access: yesExperimental Physiology, EarlyView.
Abstract Sarcopenia and frailty are complex geriatric syndromes influenced by a combination of genetic and environmental factors. Recent studies suggest that specific genetic variants, DNA methylation patterns and shortened telomeres are associated with age‐related diseases and might contribute to the development of both sarcopenia and frailty. In this
Valentina Ginevičienė   +10 more
wiley   +1 more source

PHARMACOECONOMICAL EVALUATION OF INVASIVE CANDIDOSIS PREVENTION IN THE NEONATES WITH VERY LOW BODY MASS

open access: yesПедиатрическая фармакология, 2006
Invasive candidiasis in premature neonates is characterized by frequent and attributive mortality. The authors carried out clinical and economic analysis of invasive candidiasis prevention in neonates with very low body mass at the delivery by means of ...
A.S. Kolbin
doaj   +2 more sources

Real‐World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis

open access: yesHematological Oncology, Volume 44, Issue 6, November 2026.
ABSTRACT In recent years the addition of the oral BCL2 inhibitor venetoclax to hypomethylating agents (HMAs) has emerged as the standard‐of‐care for patients with acute myeloid leukemia (AML) who are not fit for intensive chemotherapy, significantly improving survival and quality‐of‐life.
Mariarita Sciumè   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy